Invited Speaker Presentations

Wednesday, October 16, 2013
Plenary session I Prevention of type 1diabetes – is it possible? The environmental determinants of diabetes in the young (TEDDY) and prospects of prevention Åke Lernmark (Sweden)
Plenary session I Prevention of type 1diabetes – is it possible? Lifestyle and insulin resistance: prevention strategies for type 1 diabetes Terence Wilkin (UK)
Symposium I Team-work in diabetes How can team collaborate to achieve an improved outcome? Lena Hanberger (Sweden)
Symposium III What is the cause of cerebral edema in diabetic ketoacidosis? How can cerebral edema during treatment of DKA be avoided? Julie Edge (UK)
Symposium III What is the cause of cerebral edema in diabetic ketoacidosis? Do the guidelines need to be changed? Joseph Wolfsdorf (USA)
Thursday, October 17, 2013
Symposium IV New treatments for type 1 diabetes C-peptide and microvascular complications of diabetes - Therapeutic possibilities John Wahren (Sweden)
Symposium IV New treatments for type 1 diabetes GLP-1, DPPIV inhibitors and metformin Brian Kennon (UK)
Symposium V Can person-centered care improve metabolic control and quality of life? Improving diabetes care for minority group adolescents – a stance in perceptions, attitudes, communication and context Marianne Törner (Sweden)
Symposium V Can person-centered care improve metabolic control and quality of life? Can person-centered care improve metabolic control and quality of life? David Marrero (USA)
Symposium VI Most girls will become mothers – issues in different types of diabetes? Maternal and perinatal outcome of pregnancies complicated by type 1 diabetes. Can we do any better? Ulf Hanson (Sweden)
Friday, October 18, 2013
Plenary session III The Scylla and Charybdis of brain function; between hyper- and hypoglycemia What causes neurocognitive dysfunction in children with diabetes: recurrent hypoglycemia, chronic hyperglycemia, or ??? Christopher Ryan (USA)
Symposium VII Nutrition and carbohydrate counting: what should be included? Do fat and protein need insulin? The complex food counting in meal-bolus calculation Ewa Pankowska (Poland)
Symposium VII Nutrition and carbohydrate counting: what should be included? How do we get teenagers interested in bolus calculations? David Cavan (UK)
Symposium VIII Pancreas cross-talks with other organs The liver-beta-cell circuit David Dunger (UK)
Symposium VIII Pancreas cross-talks with other organs Brain pancreas cross talk Mark Evans (UK)
Saturday, October 19, 2013
Plenary Session IV Long-term diabetes complications Long-term diabetes complications - the global perspective - situation and resource availability Graham Ogle (Australia)
Symposium X Clinical outcomes from population-based diabetes registries Clinical outcomes from population-based diabetes registries Isabelle Steineck (Sweden)
Symposium XI Successful initiatives in emerging countries: GPED Symposium China: World Diabetes Foundation project on diabetes in children Luo Xiaoping (China)
Symposium XII Type 2 diabetes, twice as bad? Which are the drugs of choice in the teenager with type 2 diabetes? Philip Zeitler (USA)